NEW YORK and BASEL, Switzerland, Jan. 2, 2019 /PRNewswire/ -- Roivant
Sciences today announced that Vivek
Ramaswamy, Founder and Chief Executive Officer of Roivant,
will present an overview of the business as well as new data
updates from private companies in the Roivant family at the 37th
Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
The company's presentation is scheduled to begin at 9:30 a.m. PT
on Monday, January 7, 2019 at the
Westin St. Francis.
In addition to Roivant, the following Vants will also be
presenting at the conference:
Myovant Sciences (NYSE: MYOV) – Dr. Lynn
Seely – Tuesday, January 8, at
9:00 a.m. PT
Urovant Sciences (NASDAQ: UROV) – Keith
Katkin – Wednesday, January 9,
at 8:00 a.m. PT
Axovant Sciences (NASDAQ: AXON) – Dr. Pavan Cheruvu –
Thursday, January 10, at 8:00 a.m. PT
Sinovant Sciences – Dr. Xinan
Chen and Dr. Rae Yuan –
Thursday, January 10, at 8:30 a.m. PT
About Roivant Sciences
Roivant aims to improve health by rapidly delivering innovative
medicines and technologies to patients. We do this by building
Vants – nimble, entrepreneurial biotech and healthcare technology
companies with a unique approach to sourcing talent, aligning
incentives, and deploying technology to drive greater efficiency in
R&D and commercialization.
For more information, please visit www.roivant.com.
Media Contact
Paul Davis
Head of Communications
paul.davis@roivant.com
View original
content:http://www.prnewswire.com/news-releases/roivant-sciences-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300771733.html
SOURCE Roivant Sciences